PapersPMID:32386521
The effect of glutamine on Dehydroepiandrosterone-induced polycystic ovary syndrome rats.
- findings
- 4
- compound
- 1
- endpoints
- 4
- Study, every finding
- animal · not in humans
- Dose studied, every finding
- 0.5 g/kg, intraperitoneal, twice on the morning after the last DHEA injection
- Population, every finding
- Female Sprague-Dawley rats, DHEA-induced PCOS model, 0.5 g/kg glutamine dose
What moved
How to read these marks →“All the detected inflammation factors [C-reactive protein, interleukin (IL)-6, IL-18, tumor necrosis factor] showed significantly higher in all the PCOS groups compared to the control group (P < 0.01), and were significantly decreased with the supplementation of 0.5 g/kg glutamine (P < 0.01).”
- Decreases C-reactive protein concentration
insufficient
- Decreases interleukin-6 concentration
insufficientreplicated ×2
- Increases superoxide dismutase activity
insufficient
“Concentrations of superoxide dismutase were significantly lower in all the PCOS groups (P < 0.01) compared to the control group, and increased significantly with the supplementation of 0.5 g/kg glutamine (P < 0.01).”
- Decreases malondialdehyde (circulating)
insufficient
“Serum concentrations of malondialdehyde, nitric oxide synthase and nitric oxide were significantly higher in PCOS group (P < 0.01) compared with the control group, and significantly decreased to the comparative levels of control group with supplementation of 0.5 g/kg glutamine (P < 0.01).”
Study record
- Design
- animal study, in vivo
- Species
- animal
- Population
- Female Sprague-Dawley rats, DHEA-induced PCOS model, four groups: control, PCOS, PCOS + 0.5 g/kg glutamine, PCOS + 1.0 g/kg glutamine (n=10/group)
- Participants
- 40
- Comparator
- not stated in the paper
- Duration
- not reported
- Endpoints measured
- 9
L-glutamine